| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |